Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,404 | -9,827 | -8,259 | -7,502 | -15,230 |
| Depreciation Amortization | 1,080 | 1,141 | 1,048 | 1,303 | 1,190 |
| Accounts receivable | 191 | -1,070 | -24 | N/A | N/A |
| Accounts payable and accrued liabilities | -207 | 166 | 566 | -326 | -196 |
| Other Working Capital | -543 | -2,077 | 1,133 | 29 | -2,572 |
| Other Operating Activity | -184 | 1,027 | -2,405 | -884 | 755 |
| Operating Cash Flow | $-9,067 | $-10,640 | $-7,941 | $-7,380 | $-16,053 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,782 | N/A | N/A | N/A | N/A |
| PPE Investments | -68 | 999 | -20 | -160 | -240 |
| Sale Of Investment | N/A | -831 | 2,799 | 3,370 | 6,842 |
| Purchase Sale Intangibles | -297 | -76 | -49 | -294 | -250 |
| Other Investing Activity | -297 | -76 | -49 | -294 | -250 |
| Investing Cash Flow | $-6,147 | $92 | $2,730 | $2,916 | $6,352 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,632 | 7,139 | 1,900 | N/A | N/A |
| Debt Repayment | -2,210 | -1,957 | N/A | -1 | -21 |
| Common Stock Issued | 15,303 | 5,070 | 2,417 | 4,744 | 9,681 |
| Other Financing Activity | -340 | -817 | -102 | 14 | 0 |
| Financing Cash Flow | $16,385 | $9,435 | $4,215 | $4,757 | $9,660 |
| Beginning Cash Position | 299 | 1,412 | 2,408 | 2,115 | 2,156 |
| End Cash Position | 1,470 | 299 | 1,412 | 2,408 | 2,115 |
| Net Cash Flow | $1,171 | $-1,113 | $-996 | $293 | $-41 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,067 | -10,640 | -7,941 | -7,380 | -16,053 |
| Capital Expenditure | -68 | -51 | -20 | -160 | -240 |
| Free Cash Flow | -9,135 | -10,691 | -7,961 | -7,540 | -16,293 |